Back to Search Start Over

Amyloid precursor protein and amyloid precursor-like protein 2 in cancer.

Authors :
Pandey P
Sliker B
Peters HL
Tuli A
Herskovitz J
Smits K
Purohit A
Singh RK
Dong J
Batra SK
Coulter DW
Solheim JC
Source :
Oncotarget [Oncotarget] 2016 Apr 12; Vol. 7 (15), pp. 19430-44.
Publication Year :
2016

Abstract

Amyloid precursor protein (APP) and its family members amyloid precursor-like protein 1 (APLP1) and amyloid precursor-like protein 2 (APLP2) are type 1 transmembrane glycoproteins that are highly conserved across species. The transcriptional regulation of APP and APLP2 is similar but not identical, and the cleavage of both proteins is regulated by phosphorylation. APP has been implicated in Alzheimer's disease causation, and in addition to its importance in neurology, APP is deregulated in cancer cells. APLP2 is likewise overexpressed in cancer cells, and APLP2 and APP are linked to increased tumor cell proliferation, migration, and invasion. In this present review, we discuss the unfolding account of these APP family members' roles in cancer progression and metastasis.

Details

Language :
English
ISSN :
1949-2553
Volume :
7
Issue :
15
Database :
MEDLINE
Journal :
Oncotarget
Publication Type :
Academic Journal
Accession number :
26840089
Full Text :
https://doi.org/10.18632/oncotarget.7103